American Society of Hematology

SHERPA: Blue

People

  1. Moskowitz
    Moskowitz
  2. Horwitz
    Horwitz
  3. Zelenetz
    Zelenetz
  4. Noy
    Noy
  5. Hamlin
    Hamlin
  6. Palomba
    Palomba
  7. Kumar
    Kumar
  8. Dogan
    Dogan
  9. Caron
    Caron
  10. Owens
    Owens

Groups

  1. Center for Hematologic Malignancies (154)
  2. Department of Medicine (154)
  3. Hematologic Malignancies, Division of (154)
  4. Lymphoma (154)
  5. Population Sciences Research Program (102)
  6. Survivorship Research (77)
  7. Department of Pathology and Laboratory Medicine (47)
  8. Sloan Kettering Institute Postdocs (47)
  9. Epidemiology and Biostatistics (41)
  10. Hematology-Oncology Fellows (36)
Search Within
  1. "Alison Moskowitz"
Formats
  1. Meeting Abstract (115)
  2. Journal Article (31)
  3. Research Letter (3)
  4. Review (3)
  5. Editorial (2)
Groups
  1. Center for Hematologic Malignancies (154)
  2. Department of Medicine (154)
  3. Hematologic Malignancies, Division of (154)
  4. Lymphoma (154)
  5. Population Sciences Research Program (102)
  6. Survivorship Research (77)

More Groups

People
  1. Alison Moskowitz (154)
  2. Steven Horwitz (102)
  3. Andrew Zelenetz (68)
  4. Ariela Noy (63)
  5. Paul Hamlin (60)
  6. Anita Kumar (54)

More People

Years
  1. 2025 (1)
  2. 2024 (8)
  3. 2023 (28)
  4. 2022 (8)
  5. 2021 (15)
  6. 2020 (16)

More Years

Publications
  1. Blood (136)
  2. Blood Advances (15)
  3. Hematology-American Society of Hematology Education Program (3)

Results (154)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Zanubrutinib, obinutuzumab, and venetoclax for first-line treatment of mantle cell lymphoma with a TP53 mutation
    Journal Article

    Kumar, A.; Soumerai, J.; Abramson, J. S.; Barnes, J. A.; Caron, P.; Chhabra, S.; Chabowska, M.; Dogan, A.; Falchi, L.; Grieve, C.; more...
    Blood (2025)

    Fulltext@MSK | Save
  • Characterization of skin response in patients with mycosis fungoides and sezary syndrome treated with mogamulizumab: A retrospective, real world cohort
    Meeting Abstract

    Christensen, R.; Stuver, R.; Dusza, S.; Epstein-Peterson, Z. D.; Ghione, P.; Horwitz, S.; Johnson, W. T.; Moskowitz, A.; Myskowski, P.; Pulitzer, M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Pembrolizumab for front-line treatment of extranodal NK/T-cell lymphoma
    Meeting Abstract

    Moskowitz, A.; Advani, R. H.; Ganesan, N.; Chang, T.; Hancock, H.; Davey, T.; Miller, T.; Gibaldi, A.; Smith, M.; Assini, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Final response and survival results from a phase II trial of pembrolizumab and entinostat in relapsed/refractory Hodgkin lymphoma
    Meeting Abstract

    Stuver, R.; Vardhana, S. A.; Ganesan, N.; Boardman, A. P.; Caron, P.; Chang, T.; David, K. A.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Brentuximab vedotin-based regimens for older patients with newly diagnosed classical Hodgkin lymphoma - International, multi-center real-world experience
    Meeting Abstract

    Luttwak, E.; Kambhampati, S.; Drill, E.; Ganesan, N.; Hofstetter, L.; Gurion, R.; Aumann, S.; Haran, A.; Geva, M.; Panossian, M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Current and upcoming treatment approaches to common subtypes of PTCL (PTCL, NOS; ALCL; and TFHs)
    Review

    Moskowitz, A. J.; Stuver, R. N.; Horwitz, S. M.
    Blood (2024)

    Fulltext@MSK | Save
  • Brentuximab vedotin and chemotherapy in relapsed/refractory Hodgkin lymphoma: A propensity score–matched analysis
    Journal Article

    Driessen, J.; de Wit, F.; Herrera, A. F.; Zinzani, P. L.; LaCasce, A. S.; Cole, P. D.; Moskowitz, C. H.; García-Sanz, R.; Fuchs, M.; Müller, H.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma
    Research Letter

    Zinzani, P. L.; Salles, G.; Moskowitz, A. J.; Santoro, A.; Mehta, A.; Barr, P. M.; Mehta-Shah, N.; Collins, G. P.; Ansell, S. M.; Brody, J. D.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP
    Journal Article

    Bantilan, K. S.; Smith, A. N.; Maurer, M. J.; Teruya-Feldstein, J.; Matasar, M. J.; Moskowitz, A. J.; Straus, D. J.; Noy, A.; Palomba, M. L.; Horwitz, S. M.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Engraftment syndrome during autologous stem cell transplant in Hodgkin lymphoma patients treated with checkpoint inhibitors: A multi-center retrospective analysis
    Meeting Abstract

    Taranto, E.; Hwang, W. T.; Alfaro, M.; Surapaneni, A. S.; Gill, S. K.; Feldman, T.; Randall, M. P.; Spinner, M. A.; Furqan, F.; Shah, N. N.; more...
    Blood (2023)

    Fulltext@MSK | Save